BCAR4 and breast carcinoma: Specifically, in human ZR-75-1 and MCF7 breast cancer cells, the forced expression of BCAR4 causes cell proliferation in the absence of estrogen and in the presence of various antiestrogens, indicating BCAR4 could considered as a proper target for the treatment of antiestrogen-resistant breast cancer51.